|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||58.99 - 59.97|
|52-week range||53.58 - 70.16|
|PE ratio (TTM)||9.04|
|Forward Dividend & Yield||N/A (N/A)|
|1y target est||N/A|
DaVita Healthcare Partners, one of the largest kidney care companies in the US, was the S&P 500's top gainer on October 16, 2017.
A handful of companies are using so-called last-mile programs to train new hires for as long as a year before taking them on as full-time members of the team.
Shares of DaVita (DVA) climbed to the top of th S&P 500 index Monday after the dialysis clinic operator revealed additional information regarding the profit its derives from patients subsidized by American Kidney Fund Charity. DaVita gained more than 4% to end the day at $56.93 a share, while the S&P 500 inched 0.18% higher today. For months, DaVita’s stock has been weighed down by questions about the American Kidney Fund, the portion of the company’s revenue dependent the charity and the huge premiums it gets paid for some services.
Looking for some investments in the healthcare sector that aren't priced at a high premium? Allergan, Gilead Sciences, and DaVita are an excellent place to start.
DaVita (DVA) tumbled to the bottom of the S&P 500 today after getting cut to Underweight from Neutral at JPMorgan. DaVita dropped 9.9% to $53.89 today, while the S&P 500 declined 0.2% to 2544.73. JPMorgan's Gary ...
J.P. Morgan says it’s time sell DaVita (DVA). The firm downgraded the chain of dialysis clinics to Underweight and cut his price target from $66 a share to $51 a share. According to theflyonthewall, updated disclosures from the American Kidney Fund added to concerns regarding how much of the company’s earnings is derived from the controversial organization.
National Oilwell Varco (NOV) helped oilfield services to the top spot. Sempre (SRE) and NiSource (NI) are boosting gas distributors. Computer peripherals are up, helped by Seagate (STX). DaVita (DVA) is ...
DaVita HealthCare Partners' (DVA) focus on acquisitions will boost the company's expansion. However, rising expenses remains headwind.
Jim Cramer rattles off his take on callers' favorite stocks, including tobacco product giant Philip Morris International.
Health regulators warned that third-party financial help for insurance premiums to patients could drive up health costs and hurt insurers bottom lines.
Federal health regulators are concerned that dialysis patients are being steered into private insurance as opposed to Medicare or Medicaid.
European shares slipped on Monday as a pullback in bank stocks more than offset a stronger tech sector, while a drop in the pound drove Britain's FTSE 100 index to further record highs. The pan-European STOXX index slid 0.4 percent, while the FTSE 100 rose 0.4 percent after hitting an all-time high of 7,243.76 points in its 10th straight session of gains. The pound sank to more than two-month lows after weekend comments from British Prime Minister Theresa May sparked talk that Britain would drastically rework trade relations with the European Union after Brexit.
European shares edged lower on Monday, while a rise among basic resources stocks helped Britain's FTSE 100 index hit a record high. The FTSE 100 gained 0.3 percent to 7,239.26 points, putting it on track for its tenth straight session of gains. "I think the appetite is there to keep (the FTSE) pushing north.
DaVita will suspend support for applications to the AKF for charitable premium assistance by patients enrolled in minimum essential Medicaid coverage.